RxDoctor Payments Data

Brandy Centers, APRN

Nurse Practitioner · Wesley Chapel, FLNPI 1225401573

Payments from drug & device makers

$16,512in general payments, 2019–2025

Across 849 payments — averaging $19.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • UCB, Inc.$1K
  • Biohaven Pharmaceuticals, Inc.$1K
  • Pfizer$917
  • Neurocrine Biosciences, Inc.$793
  • Amgen$771
  • plus $8K from 51 others

What the payments were for

  • Consulting fees$8005%
  • Food & beverage$15,61195%
  • Education$1001%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)201$3,624
UCB, Inc.76$1,428
Biohaven Pharmaceuticals, Inc.15$1,006
Pfizer55$917
Neurocrine Biosciences, Inc.41$793
Amgen(2 entities)46$771
Teva Pharmaceuticals USA, Inc.43$644
Eisai Inc.20$429
Novartis26$415
Lilly USA, LLC24$394
Lundbeck LLC16$366
Impel Pharmaceuticals Inc.14$343
AstraZeneca14$332
Biohaven Pharmaceutical Holding Company Ltd.18$265
Sanofi13$264
MDD US Operations, LLC16$263
Otsuka America Pharmaceutical, Inc.13$263
Biogen12$254
CSL Behring13$247
Bristol Myers Squibb16$185
Takeda Pharmaceuticals U.S.A., Inc.6$182
Jazz Pharmaceuticals Inc.12$176
Amneal Pharmaceuticals LLC9$174
Avanir Pharmaceuticals, Inc.7$170
Catalyst Pharmaceuticals, Inc.8$165
TG Therapeutics, Inc.7$163
Argenx US, Inc.7$155
Upsher-smith Laboratories LLC7$152
Tanabe Pharma America, Inc.5$144
Acorda Therapeutics, Inc7$141
Sumitomo Pharma America, Inc.8$140
Johnson & Johnson(2 entities)6$131
Insightec,inc2$128
SK Life Science, Inc.5$119
EMD Serono, Inc.4$99
Acadia Pharmaceuticals Inc6$95
Scilex Pharmaceuticals Inc.4$90
Neurelis, Inc.5$82
Sunovion Pharmaceuticals Inc.4$72
Genentech USA, Inc.3$65
Avion Pharmaceuticals3$62
Merz Pharmaceuticals, LLC3$61
Boston Scientific3$57
Supernus Pharmaceuticals, Inc.3$55
Currax Pharmaceuticals LLC4$54
C2n Diagnostics, LLC2$45
Arbor Pharmaceuticals, Inc.2$44
Impel Pharmaceuticals LLC2$40
Mallinckrodt Hospital Products Inc.2$40
Banner Life Sciences, LLC3$38
Collegium Pharmaceutical, Inc.2$34
Axsome Therapeutics, Inc.1$26
Microtransponder, Inc.1$25
Livanova USA, Inc.1$23
Xeris Pharmaceuticals, Inc.1$22
Kyowa Kirin, Inc.1$21
Nevro Corp.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,512 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Medicare billing

Part B allowed, 2024
$48,087
Medicare patients
197
Services billed
2,985

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate24$46,159
BotoxOnabotulinumtoxina28$34,889
UbrelvyUbrogepant15$20,194
QuliptaAtogepant12$13,913
Aimovig AutoinjectorErenumab-Aooe13$12,661
Emgality PenGalcanezumab-Gnlm12$11,845
Memantine Hcl118$3,276
Gabapentin101$2,176
Duloxetine Hcl42$1,148
Lamotrigine56$918
Levetiracetam33$838
Phenytoin Sodium Extended26$700
Lacosamide11$610
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine27$577
Topiramate43$572

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieBotox, Ubrelvy, Qulipta$3,624$68,99655 claims
PfizerNurtec Odt$917$46,15924 claims
Upsher-smith Laboratories LLCTopiramate$152$57243 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in Wesley Chapel

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →